AMA
Barczak A. Diagnostic utility of Addenbrooke’s Cognitive Examination III
in differentiating Alzheimer’s disease dementia, vascular dementia,
and mixed dementia. Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii. 2026;35(2):85-93. doi:10.5114/ppn.2026.161371.
APA
Barczak, A. (2026). Diagnostic utility of Addenbrooke’s Cognitive Examination III
in differentiating Alzheimer’s disease dementia, vascular dementia,
and mixed dementia. Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii, 35(2), 85-93. https://doi.org/10.5114/ppn.2026.161371
Chicago
Barczak, Anna. 2026. "Diagnostic utility of Addenbrooke’s Cognitive Examination III
in differentiating Alzheimer’s disease dementia, vascular dementia,
and mixed dementia". Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii 35 (2): 85-93. doi:10.5114/ppn.2026.161371.
Harvard
Barczak, A. (2026). Diagnostic utility of Addenbrooke’s Cognitive Examination III
in differentiating Alzheimer’s disease dementia, vascular dementia,
and mixed dementia. Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii, 35(2), pp.85-93. https://doi.org/10.5114/ppn.2026.161371
MLA
Barczak, Anna. "Diagnostic utility of Addenbrooke’s Cognitive Examination III
in differentiating Alzheimer’s disease dementia, vascular dementia,
and mixed dementia." Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii, vol. 35, no. 2, 2026, pp. 85-93. doi:10.5114/ppn.2026.161371.
Vancouver
Barczak A. Diagnostic utility of Addenbrooke’s Cognitive Examination III
in differentiating Alzheimer’s disease dementia, vascular dementia,
and mixed dementia. Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii. 2026;35(2):85-93. doi:10.5114/ppn.2026.161371.
